{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:44:10Z","timestamp":1780926250343,"version":"3.54.1"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with muscle-invasive bladder cancer face a poor prognosis due to rapid disease progression and chemoresistance. Thus, there is an urgent need for a new therapeutic treatment. The tumor microenvironment (TME) has crucial roles in tumor development, growth, progression, and therapy resistance. TME cells may also survive standard treatment of care and fire up disease recurrence. However, whether specific TME components have tumor-promoting or tumor-inhibitory properties depends on cell type and cancer entity. Thus, a deeper understanding of the interaction mechanisms between the TME and cancer cells is needed to develop new cancer treatment approaches that overcome therapy resistance. Little is known about the function and interaction between mesenchymal stromal cells (MSC) or fibroblasts (FB) as TME components and bladder cancer cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We investigated the functional impact of conditioned media (CM) from primary cultures of different donors of MSC or FB on urothelial carcinoma cell lines (UCC) representing advanced disease stages, namely, BFTC-905, VMCUB-1, and UMUC-3. Underlying mechanisms were identified by RNA sequencing and protein analyses of cancer cells and of conditioned media by oncoarrays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Both FB- and MSC-CM had tumor-promoting effects on UCC. In some experiments, the impact of MSC-CM was more pronounced. CM augmented the aggressive phenotype of UCC, particularly of those with epithelial phenotype. Proliferation and migratory and invasive capacity were significantly increased; cisplatin sensitivity was reduced. RNA sequencing identified underlying mechanisms and molecules contributing to the observed phenotype changes. NRF2 and NF-\u03baB signaling was affected, contributing to improved cisplatin detoxification. Likewise, interferon type I signaling was downregulated and regulators of epithelial mesenchymal transition (EMT) were increased. Altered protein abundance of CXCR4, hyaluronan receptor CD44, or TGF\u03b2-signaling was induced by CM in cancer cells and may contribute to phenotypical changes. CM contained high levels of CCL2\/MCP-1, MMPs, and interleukins which are well known for their impact on other cancer entities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The CM of two different TME components had overlapping tumor-promoting effects and increased chemoresistance. We identified underlying mechanisms and molecules contributing to the aggressiveness of bladder cancer cells. These need to be further investigated for targeting the TME to improve cancer therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1228185","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:28:28Z","timestamp":1694636908000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells"],"prefix":"10.3389","volume":"13","author":[{"given":"Lucie M.","family":"Frerichs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Frerichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Petzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"K\u00f6hrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Windolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bittersohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le J.","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Grotheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.23162","article-title":"A real-world data study to evaluate treatment patterns, clinical characteristics and survival outcomes for first- and second-line treatment in locally advanced and metastatic urothelial cancer patients in germany","volume":"9","author":"Niegisch","year":"2018","journal-title":"J Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.757","article-title":"Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer","volume":"23","author":"von der Maase","year":"2005","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(00)00156-8","article-title":"Know thy neighbor: stromal cells can contribute oncogenic signals","volume":"11","author":"Tlsty","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.5133","article-title":"Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation","volume":"264","author":"Elenbaas","year":"2001","journal-title":"Exp Cell Res"},{"key":"B7","article-title":"Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma","volume":"45","author":"Gan","year":"2021","journal-title":"Oncol Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1860","article-title":"Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta","volume":"64","author":"M\u00fcerk\u00f6ster","year":"2004","journal-title":"Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41419-018-0808-2","article-title":"Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance","volume":"9","author":"Che","year":"2018","journal-title":"Cell Death Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.3390\/ijms22041912","article-title":"Sensitivity to cisplatin in head and neck cancer cells is significantly affected by patient-derived cancer-associated fibroblasts","volume":"22","author":"Peltanova","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2023.02.011","article-title":"Cancer-associated fibroblasts in bladder cancer: Origin, biology, and therapeutic opportunities","volume":"6","author":"Caramelo","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.3390\/ijms20092256","article-title":"Activated fibroblast program orchestrates tumor initiation and progression; molecular mechanisms and the associated therapeutic strategies","volume":"20","author":"Yoshida","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2019.02.025","article-title":"A systematic investigation of the malignant functions and diagnostic potential of the cancer secretome","volume":"26","author":"Robinson","year":"2019","journal-title":"Cell Rep"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/stem.559","article-title":"Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth","volume":"29","author":"Klopp","year":"2011","journal-title":"Stem Cells"},{"key":"B15","article-title":"Influence of human adipose stem cells on prostate cancer cell growth","volume":"82","author":"Tokunori","year":"2020","journal-title":"Nagoya J Med Sci"},{"key":"B16","article-title":"Breast cancer treatment by adipose-derived stem cells: an experimental study","volume":"9","author":"Illouz","year":"2014","journal-title":"J Stem Cells"},{"key":"B17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13058-019-1131-2","article-title":"The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells","volume":"21","author":"Ryan","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e887","DOI":"10.1038\/cddis.2013.384","article-title":"Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation","volume":"4","author":"Castells","year":"2013","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12964-018-0215-4","article-title":"Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma\/stem cells (MSC)","volume":"16","author":"Melzer","year":"2018","journal-title":"Cell Commun Signal"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41598-019-55013-0","article-title":"Fibroblasts in urothelial bladder cancer define stroma phenotypes that are associated with clinical outcome","volume":"10","author":"Mezheyeuski","year":"2020","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.016576","article-title":"Prognostic significance of tenascin-c expression in superficial and invasive bladder cancer","volume":"57","author":"Brunner","year":"2004","journal-title":"J Clin pathology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2008.00724.x","article-title":"Multilineage differentiation potential of human dermal skin-derived fibroblasts","volume":"17","author":"Lorenz","year":"2008","journal-title":"Exp Dermatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.3.1595","article-title":"Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells","volume":"179","author":"Haniffa","year":"2007","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.12968\/jowc.2013.22.8.407","article-title":"Wound healing and the role of fibroblasts","volume":"22","author":"Bainbridge","year":"2013","journal-title":"J Wound Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-015-9477-2","article-title":"The pathogenic role of angiogenesis in rheumatoid arthritis","volume":"18","author":"Elshabrawy","year":"2015","journal-title":"Angiogenesis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1242\/dev.128.16.3117","article-title":"The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells","volume":"128","author":"Simian","year":"2001","journal-title":"Development"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11354","article-title":"Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response","volume":"7","author":"O'Malley","year":"2016","journal-title":"Oncotarget"},{"key":"B32","first-page":"83","article-title":"Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method","volume":"2","author":"Friedenstein","year":"1974","journal-title":"Exp Hematol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2010.01.013","article-title":"Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms","volume":"316","author":"Ghajar","year":"2010","journal-title":"Exp Cell Res"},{"key":"B34","article-title":"Immunomodulatory properties of mesenchymal stromal cells: Still unresolved \u201cYin and yang\u201d","volume":"14","author":"Alessandro","year":"2019","journal-title":"Curr Stem Cell Res Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12964-016-0143-0","article-title":"Interaction of MSC with tumor cells","volume":"14","author":"Melzer","year":"2016","journal-title":"Cell Communication Signaling"},{"key":"B36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/10_2009_24","article-title":"Isolation, characterization, differentiation, and application of adipose-derived stem cells","volume":"123","author":"Kuhbier","year":"2010","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.5966\/sctm.2012-0184","article-title":"Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts","volume":"2","author":"Melief","year":"2013","journal-title":"Stem Cells Trans Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.a.22402","article-title":"Human adult stem cells from diverse origins: An overview from multiparametric immunophenotyping to clinical applications","volume":"85","author":"Sousa","year":"2014","journal-title":"Cytometry Part A"},{"key":"B39","article-title":"Isolation and multipotential differentiation of mesenchymal stromal cell\u2212like progenitor cells from human bladder","volume":"19","author":"Lu","year":"2019","journal-title":"Mol Med Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.3390\/ijms24054760","article-title":"Crosstalk between mesenchymal stem cells and cancer stem cells reveals a novel stemness-related signature to predict prognosis and immunotherapy responses for bladder cancer patients","volume":"24","author":"Ma","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-019-0960-z","article-title":"Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer","volume":"18","author":"Plava","year":"2019","journal-title":"Mol Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28456","article-title":"Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells","volume":"234","author":"Ko","year":"2019","journal-title":"J Cell Physiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.545126","article-title":"Tumor microenvironment uses a reversible reprogramming of mesenchymal stromal cells to mediate pro-tumorigenic effects","volume":"8","author":"Nwabo Kamdje","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"101505","DOI":"10.1016\/j.tice.2021.101505","article-title":"Assessing the effect of human mesenchymal stem cell-derived conditioned media on human cancer cell lines: A systematic review","volume":"71","author":"Raj","year":"2021","journal-title":"Tissue Cell"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-59038-3_17","article-title":"The tumor microenvironment of bladder cancer","volume":"1296","author":"Hatogai","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol Biol Cell"},{"key":"B47","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1038\/s41598-021-91501-y","article-title":"Osteogenic differentiation of human mesenchymal stromal cells and fibroblasts differs depending on tissue origin and replicative senescence","volume":"11","author":"Grotheer","year":"2021","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1159\/000232157","article-title":"Adipogenic, chondrogenic and osteogenic differentiation of clonally derived human dermal fibroblasts","volume":"191","author":"Junker","year":"2010","journal-title":"Cells Tissues Organs"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-180167","article-title":"Systematic review: Characteristics and preclinical uses of bladder cancer cell lines","volume":"4","author":"Zuiverloon","year":"2018","journal-title":"Bladder Cancer"},{"key":"B50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s12864-015-1450-3","article-title":"The UBC-40 urothelial bladder cancer cell line index: a genomic resource for functional studies","volume":"16","author":"Earl","year":"2015","journal-title":"BMC Genomics"},{"key":"B51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3390\/cancers11040481","article-title":"Contingencies of UTX\/KDM6A action in urothelial carcinoma","volume":"11","author":"Lang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B52","volume-title":"An interactive tool for comparing lists with venn diagrams","author":"Oliveros","year":"2007"},{"key":"B53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc"},{"key":"B54","doi-asserted-by":"publisher","first-page":"561098","DOI":"10.1155\/2013\/561098","article-title":"Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1\/CXCR4 axis","volume":"2013","author":"Marquez-Curtis","year":"2013","journal-title":"BioMed Res Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e10126","DOI":"10.1002\/jbm4.10126","article-title":"Bone as a preferential site for metastasis","volume":"3","author":"Sowder","year":"2019","journal-title":"JBMR Plus"},{"key":"B56","first-page":"241","article-title":"CD44: Structure, function and association with the malignant process","volume-title":"Advances in cancer research","author":"Naor","year":"1997"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.11.026","article-title":"The role of proteases in transforming growth factor-beta activation","volume":"40","author":"Jenkins","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120137","article-title":"Simvastatin modulates mesenchymal stromal cell proliferation and gene expression","volume":"10","author":"Zanette","year":"2015","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.600350","article-title":"Obesity-related fatty acid and cholesterol metabolism in cancer-associated host cells","volume":"8","author":"Ye","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B61","first-page":"1","article-title":"Cholesterol metabolism and colon cancer","volume":"17","author":"Broitman","year":"1993","journal-title":"Prog Food Nutr Sci"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.831099","article-title":"Contribution of MicroRNAs in chemoresistance to cisplatin in the top five deadliest cancer: An updated review","volume":"13","author":"Loren","year":"2022","journal-title":"Front Pharmacol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: A global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010217","article-title":"Role of JAK\/STAT3 signaling in the regulation of metastasis, the transition of cancer stem cells, and chemoresistance of cancer by epithelial-mesenchymal transition","volume":"9","author":"Jin","year":"2020","journal-title":"Cells"},{"key":"B65","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3390\/ijms19020590","article-title":"Multifaceted mechanisms of cisplatin resistance in long-term treated urothelial carcinoma cell lines","volume":"19","author":"Skowron","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cbf.3320","article-title":"Mesenchymal stem cells promote cell invasion and migration and autophagy-induced epithelial-mesenchymal transition in A549 lung adenocarcinoma cells","volume":"36","author":"Luo","year":"2018","journal-title":"Cell Biochem Funct"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-19-0665","article-title":"An emerging regulatory role for the tumor microenvironment in the DNA damage response to double-strand breaks","volume":"18","author":"Lama-Sherpa","year":"2020","journal-title":"Mol Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2010.05.006","article-title":"The tumor microenvironment and DNA repair","volume":"20","author":"Klein","year":"2010","journal-title":"Semin Radiat Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1477","article-title":"Friends or foes - bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2949","article-title":"Genetic subtyping and phenotypic characterization of the immune microenvironment and MYC\/BCL2 double expression reveal heterogeneity in diffuse large b-cell lymphoma","volume":"28","author":"Xu-Monette","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25794","article-title":"Influence of mesenchymal stem cells conditioned media on proliferation of urinary tract cancer cell lines and their sensitivity to ciprofloxacin","volume":"118","author":"Maj","year":"2017","journal-title":"J Cell Biochem"},{"key":"B72","doi-asserted-by":"publisher","first-page":"15118","DOI":"10.1038\/s41598-018-33397-9","article-title":"The interplay between adipose-derived stem cells and bladder cancer cells","volume":"8","author":"Maj","year":"2018","journal-title":"Sci Rep"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28436","article-title":"The effects of adipose-derived stem cells on CD133-expressing bladder cancer cells","volume":"120","author":"Maj","year":"2019","journal-title":"J Cell Biochem"},{"key":"B74","doi-asserted-by":"crossref","first-page":"185943","DOI":"10.1155\/2012\/185943","article-title":"Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedside","volume":"2012","author":"Ku\u00e7i","year":"2012","journal-title":"Stem Cells Int"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F","article-title":"Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation","volume":"64","author":"Bruder","year":"1997","journal-title":"J Cell Biochem"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/ijms18071586","article-title":"The role of tumor microenvironment in chemoresistance: To survive, keep your enemies closer","volume":"18","author":"Senthebane","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.043","article-title":"Tumor microenvironment and therapeutic response","volume":"387","author":"Wu","year":"2017","journal-title":"Cancer Lett"},{"key":"B78","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cancers15020376","article-title":"The tumor microenvironment in tumorigenesis and therapy resistance revisited","volume":"15","author":"Dzobo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/pros.21206","article-title":"Adipose tissue-derived stem cells promote prostate tumor growth","volume":"70","author":"Prantl","year":"2010","journal-title":"Prostate"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45273","article-title":"Human ovarian carcinoma\u2013associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production","volume":"121","author":"McLean","year":"2011","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41419-017-0176-3","article-title":"Human colorectal cancer-derived mesenchymal stem cells promote colorectal cancer progression through IL-6\/JAK2\/STAT3 signaling","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41419-019-1622-1","article-title":"Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin \u03b15 in hepatocellular carcinoma","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Disease"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00623","article-title":"CK14 expression identifies a Basal\/Squamous-like type of papillary non-Muscle-Invasive upper tract urothelial carcinoma","volume":"10","author":"Jung","year":"2020","journal-title":"Front Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3390\/ijms23052801","article-title":"Dickkopf-1 promotes angiogenesis and is a biomarker for hepatic stem cell-like hepatocellular carcinoma","volume":"23","author":"Suda","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02157.x","article-title":"Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia","volume":"110","author":"M\u00f6hle","year":"2000","journal-title":"Br J Haematol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.01.053","article-title":"CXCR4\/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors","volume":"152","author":"Mo","year":"2013","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13058-023-01665-w","article-title":"Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment","volume":"25","author":"Liu","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00757","article-title":"Tumor-Stroma-Inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer","volume":"10","author":"Liubomirski","year":"2019","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/nature06188","article-title":"Mesenchymal stem cells within tumour stroma promote breast cancer metastasis","volume":"449","author":"Karnoub","year":"2007","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/CMR.0000000000000325","article-title":"Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-\u03b2","volume":"27","author":"Lv","year":"2017","journal-title":"Melanoma Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.4161\/cam.25138","article-title":"Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases","volume":"7","author":"Swamydas","year":"2013","journal-title":"Cell Adh Migr"},{"key":"B93","article-title":"Mesenchymal stem cell\u2212derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway","volume":"54","author":"Zhou","year":"2019","journal-title":"Int J Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-012-0998-0","article-title":"Expression of the e-cadherin repressors snail, slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells","volume":"138","author":"Schulte","year":"2012","journal-title":"Histochem Cell Biol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.01.063","article-title":"Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor","volume":"69","author":"Wang","year":"2007","journal-title":"Urology"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00236","article-title":"Hyaluronan, inflammation, and breast cancer progression","volume":"6","author":"Schwertfeger","year":"2015","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2012.569","article-title":"Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer","volume":"108","author":"Provenzano","year":"2013","journal-title":"Br J Cancer"},{"key":"B98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gutjnl-2012-302529","article-title":"Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer","volume":"62","author":"Jacobetz","year":"2013","journal-title":"Gut"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.782448","article-title":"Epigenetic priming of bladder cancer cells with decitabine increases cytotoxicity of human EGFR and CD44v6 CAR engineered t-cells","volume":"12","author":"Grunewald","year":"2021","journal-title":"Front Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11684-016-0431-5","article-title":"Breast cancer-associated fibroblasts: their roles in tumor initiation, progression and clinical applications","volume":"10","author":"Qiao","year":"2016","journal-title":"Front Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10585-012-9473-5","article-title":"Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models","volume":"29","author":"Zollo","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","article-title":"TGF-\u03b2-Mediated epithelial-mesenchymal transition and cancer metastasis","volume":"20","author":"Hao","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.5292","article-title":"Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-\u03b21\/Smad signaling pathway","volume":"37","author":"Wang","year":"2017","journal-title":"Oncol Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"12186","DOI":"10.1038\/s41598-022-16518-3","article-title":"PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity","volume":"12","author":"Furuya","year":"2022","journal-title":"Sci Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2008.39","article-title":"Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells","volume":"15","author":"Spaeth","year":"2008","journal-title":"Gene Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00343-0","article-title":"Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer","volume":"22","author":"Zhang","year":"2021","journal-title":"Lancet Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20946","article-title":"Snail, slug, and smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma","volume":"103","author":"Elloul","year":"2005","journal-title":"Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2926","article-title":"Epithelial to mesenchymal transition: Expression of the regulators snail, slug, and twist in pancreatic cancer","volume":"13","author":"Hotz","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-1275-z","article-title":"The transcriptional repressor SNAIL is overexpressed in human colon cancer","volume":"50","author":"Roy","year":"2005","journal-title":"Digestive Dis Sci"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4161\/cam.21687","article-title":"The role of snail in prostate cancer","volume":"6","author":"Smith","year":"2012","journal-title":"Cell Adhesion Migration"},{"key":"B112","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-022-04788-8","article-title":"TGF-\u03b2 induces GBM mesenchymal transition through upregulation of CLDN4 and nuclear translocation to activate TNF-\u03b1\/NF-\u03baB signal pathway","volume":"13","author":"Yan","year":"2022","journal-title":"Cell Death Disease"},{"key":"B113","doi-asserted-by":"publisher","first-page":"8340","DOI":"10.3390\/ijms21218340","article-title":"Role of nuclear claudin-4 in renal cell carcinoma","volume":"21","author":"Owari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-009-9194-7","article-title":"Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer","volume":"28","author":"McConkey","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.043","article-title":"TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma","volume":"160","author":"Oshimori","year":"2015","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2819","article-title":"Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer","volume":"69","author":"Arumugam","year":"2009","journal-title":"Cancer Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3390\/ijms18081680","article-title":"Various mechanisms involve the nuclear factor (Erythroid-derived 2)-like (NRF2) to achieve cytoprotection in long-term cisplatin-treated urothelial carcinoma cell lines","volume":"18","author":"Skowron","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13046-015-0259-x","article-title":"Phenotype plasticity rather than repopulation from CD90\/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines","volume":"34","author":"Skowron","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.02.006","article-title":"The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer","volume":"32","author":"Hayden","year":"2014","journal-title":"Urologic Oncology: Semin Original Investigations"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1021\/jm060960h","article-title":"Chemoinformatics analysis identifies cytotoxic compounds susceptible to chemoresistance mediated by glutathione and cystine\/glutamate transport system xc","volume":"50","author":"Dai","year":"2007","journal-title":"J Med Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3256","article-title":"NF-\u03baB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression","volume":"48","author":"Sun","year":"2016","journal-title":"Int J Oncol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-2306","article-title":"Hypoxia induces transcriptional and translational downregulation of the type i IFN pathway in multiple cancer cell types","volume":"80","author":"Miar","year":"2020","journal-title":"Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3558","article-title":"Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing","volume":"17","author":"Chen","year":"2016","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1228185\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:28:42Z","timestamp":1694636922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1228185\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":124,"alternative-id":["10.3389\/fonc.2023.1228185"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1228185","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"article-number":"1228185"}}